Evidence map›Paper›PMID 33050528›Full record

ArticleCancers2020

Sphingolipid Pathway as a Source of Vulnerability in IDH1

Tyrone Dowdy, Lumin Zhang, Orieta Celiku, Sriya Movva, Adrian Lita, Victor Ruiz-Rodado, Mark R Gilbert, Mioara Larion

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Targeting the Sphingolipid Rheostat in Gliomas.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Biomedicines · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tyrone DowdyNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Lumin ZhangNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Orieta CelikuNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.ORCID 0000-0002-0500-1032
Sriya MovvaGeorge Washington School of Medicine and Health Sciences, Washington, DC 20052, USA.
Adrian LitaNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Victor Ruiz-RodadoNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Mark R GilbertNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Mioara LarionNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.ORCID 0000-0002-7016-9587
National Institutes of Health · USGeorge Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to providing integrity to cellular structure, the various classes of lipids participate in a multitude of functions including secondary messengers, receptor stimulation, lymphocyte trafficking, inflammation, angiogenesis, cell migration, proliferation, necrosis and apoptosis, thus highlighting the importance of understanding their role in the tumor phenotype. In the context of IDH1

Indexed as

IDHmut gliomasN,N-dimethylsphingosinesphinganinesphingolipid metabolismsphingosine

Identifiers

PMID33050528
PMCPMC7601159
OpenAlexW3091912286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.